These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8077867)

  • 1. [Ambulatory heparin-antivitamin K relay].
    Plettner JL
    J Mal Vasc; 1994; 19(2):154-7. PubMed ID: 8077867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties].
    Ferrari E; Schiano N; Benhamou M; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1301-6. PubMed ID: 11794973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Which antithrombotic agents should be prescribed in deep venous thrombosis of the limbs?].
    Fiessinger JN
    Presse Med; 1994 Mar; 23(11):509-10. PubMed ID: 8022737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [When is antivitamin K therapy indicated in the stable coronary patient?].
    Ferrari E; Serre S; Lesto I; Berkane N; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1274-7. PubMed ID: 11794969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment of venous thromboembolism.
    Becattini C; Agnelli G; Emmerich J; Bura A; Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):242-50. PubMed ID: 16953263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the efficacy of a low dose of antivitamin K and a preventive dose of low molecular weight heparin in the prevention of relapses of deep venous thrombosis after curative treatment in the aged subject].
    Pistorius MA; Said L; Planchon B
    J Mal Vasc; 1994; 19(1):68. PubMed ID: 8027686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of immunoallergic thrombopenia induced by heparin].
    Grouille D; Sardin B; Colin D; Boulogne P
    Cah Anesthesiol; 1988; 36(4):261-3. PubMed ID: 3167631
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Before administering oral anticoagulant therapy with vitamin K antagonists, should heparin be administered, even when therapy is purely of preventive intent without an acute clinical manifestation?].
    Seitz R
    Internist (Berl); 1995 Nov; 36(11):1099-100. PubMed ID: 8543448
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heparins and antivitamins K].
    Langer B
    Rev Paul Med; 1990; 108(4):183-8. PubMed ID: 2095622
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thromboembolic complications following hip arthroplasty. Role of systematic heparin therapy (130 cases)].
    Raimbeau G; Galland F; Pidhorz L
    Ann Chir; 1983 May; 37(4):291-5. PubMed ID: 6625504
    [No Abstract]   [Full Text] [Related]  

  • 15. [Patient card. Tips on taking an oral anticoagulant (antivitamin K)].
    Rev Prat; 2004 Feb; 54(3):310. PubMed ID: 15134240
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prescription and monitoring of antithrombotic treatment. First part: anticoagulants].
    Boneu B
    Rev Prat; 2004 Mar; 54(6):651-6. PubMed ID: 15222619
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monitoring antivitamin K treatment: a notebook for the patient].
    Buxeraud J
    Rev Infirm; 2004 Apr; (100):38-41. PubMed ID: 15222184
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M; Desruennes E; Di Palma M
    Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
    Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
    [No Abstract]   [Full Text] [Related]  

  • 20. [Death of Sintrom?].
    Vogel J
    Rev Med Suisse; 2012 Jan; 8(325):164-5. PubMed ID: 22338498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.